Xadago has been approved as a supplementary medication for patients with Parkinson's disease who are having "off" episodes or whose disease is progressing.
Adam S. Whalley, PharmD
Advertisement
Adam S. Whalley, PharmD is a PGY-1 pharmacy resident at UConn John Dempsey Hospital at UConn Health, Farmington, CT
Articles by Adam S. Whalley, PharmD
Advertisement
Latest Updated Articles
- Safinamide (Xadago): Approved as Add-On for Parkinson’s
Published: June 13th 2017 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Approves Enflonsia for the Prevention of RSV Lower Respiratory Tract Disease in Infants
2
Pharmacists Experience Challenges in Credentialing, Billing for Services | NCPA 2025
3
Pharmacy Technology Should Focus on Patient Engagement, Peer Insight | NCPA 2025
4
How Pharmacies’ Ability to Provide Behavioral Health Services is Growing | NCPA 2025
5
